Literature DB >> 17043653

AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture.

K Oyama1, T Okawa, H Nakagawa, M Takaoka, C D Andl, S-H Kim, A Klein-Szanto, J A Diehl, M Herlyn, W El-Deiry, A K Rustgi.   

Abstract

Epidermal growth factor receptor (EGFR) overexpression and activation is critical in the initiation and progression of cancers, especially those of epithelial origin. EGFR activation is associated with the induction of divergent signal transduction pathways and a gamut of cellular processes; however, the cell-type and tissue-type specificity conferred by certain pathways remains to be elucidated. In the context of the esophageal epithelium, a prototype stratified squamous epithelium, EGFR overexpression is relevant in the earliest events of carcinogenesis as modeled in a three-dimensional organotypic culture system. We demonstrate that the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway, and not the MEK/MAPK (mitogen-activated protein kinase) pathway, is preferentially activated in EGFR-mediated esophageal epithelial hyperplasia, a premalignant lesion. The hyperplasia was abolished with direct inhibition of PI3K and of AKT but not with inhibition of the MAPK pathway. With the introduction of an inducible AKT vector in both primary and immortalized esophageal epithelial cells, we find that AKT overexpression and activation is permissive for complete epithelial formation in organotypic culture, but imposes a growth constraint in cells grown in monolayer. In organotypic culture, AKT mediates changes related to cell shape and size with an expansion of the differentiated compartment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043653      PMCID: PMC2996093          DOI: 10.1038/sj.onc.1210025

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

Review 1.  Signaling--2000 and beyond.

Authors:  T Hunter
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.

Authors:  F Scholle; K M Bendt; N Raab-Traub
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

Authors:  N Prenzel; O M Fischer; S Streit; S Hart; A Ullrich
Journal:  Endocr Relat Cancer       Date:  2001-03       Impact factor: 5.678

4.  Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma.

Authors:  Young Tae Kim; Sang Won Park; Jae Wook Kim
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

5.  Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway.

Authors:  Elzbieta Janda; Gabi Litos; Stefan Grünert; Julian Downward; Hartmut Beug
Journal:  Oncogene       Date:  2002-08-01       Impact factor: 9.867

6.  Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.

Authors:  J Okano; I Gaslightwala; M J Birnbaum; A K Rustgi; H Nakagawa
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 7.  The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.

Authors:  E S Kandel; N Hay
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

8.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

Review 9.  Genetic steps in the development of squamous cell carcinoma of the esophagus.

Authors:  A M Mandard; P Hainaut; M Hollstein
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

10.  The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells.

Authors:  Takayuki Kamei; Stephanie R Jones; Belinda M Chapman; Kerry L MCGonigle; Guoli Dai; Michael J Soares
Journal:  Mol Endocrinol       Date:  2002-07
View more
  24 in total

1.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.

Authors:  Shinya Ohashi; Mitsuteru Natsuizaka; Gabrielle S Wong; Carmen Z Michaylira; Katharine D Grugan; Douglas B Stairs; Jiri Kalabis; Maria E Vega; Ross A Kalman; Momo Nakagawa; Andres J Klein-Szanto; Meenhard Herlyn; J Alan Diehl; Anil K Rustgi; Hiroshi Nakagawa
Journal:  Cancer Res       Date:  2010-04-27       Impact factor: 12.701

Review 2.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

3.  A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells.

Authors:  Giuseppa Augello; Roberto Puleio; Maria Rita Emma; Antonella Cusimano; Guido R Loria; James A McCubrey; Giuseppe Montalto; Melchiorre Cervello
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

4.  Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer.

Authors:  Shaoxiang Wang; Zhan Du; Jie Luo; Xiao Wang; Haiying Li; Yuting Liu; Yong Zhang; Jiwei Ma; Weiwei Xiao; Yifei Wang; Xueyun Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

5.  JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.

Authors:  Nicole D Facompre; Kayla M Harmeyer; Xavier Sole; Sheheryar Kabraji; Zachary Belden; Varun Sahu; Kelly Whelan; Koji Tanaka; Gregory S Weinstein; Kathleen T Montone; Alexander Roesch; Phyllis A Gimotty; Meenhard Herlyn; Anil K Rustgi; Hiroshi Nakagawa; Sridhar Ramaswamy; Devraj Basu
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

6.  Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture.

Authors:  Jiri Kalabis; Gabrielle S Wong; Maria E Vega; Mitsuteru Natsuizaka; Erle S Robertson; Meenhard Herlyn; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Nat Protoc       Date:  2012-01-12       Impact factor: 13.491

Review 7.  Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?

Authors:  Corinne Abbadie; Olivier Pluquet; Albin Pourtier
Journal:  Cell Mol Life Sci       Date:  2017-07-13       Impact factor: 9.261

8.  TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.

Authors:  Diana M Lim; Sneha Narasimhan; Carmen Z Michaylira; Mei-Lun Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

9.  Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.

Authors:  Raghu Kadaba; Hanna Birke; Jun Wang; Steven Hooper; Claudia D Andl; Francesco Di Maggio; Erdinc Soylu; Mohammed Ghallab; Daniel Bor; Fieke Em Froeling; Satyajit Bhattacharya; Anil K Rustgi; Erik Sahai; Claude Chelala; Peter Sasieni; Hemant M Kocher
Journal:  J Pathol       Date:  2013-03-21       Impact factor: 7.996

10.  The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.

Authors:  Takaomi Okawa; Carmen Z Michaylira; Jiri Kalabis; Douglas B Stairs; Hiroshi Nakagawa; Claudia D Andl; Cameron N Johnstone; Andres J Klein-Szanto; Wafik S El-Deiry; Edna Cukierman; Meenhard Herlyn; Anil K Rustgi
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.